BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 187 filers reported holding BLUEBIRD BIO INC in Q4 2023. The put-call ratio across all filers is 1.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,288 | +44.1% | 423,733 | +56.0% | 0.01% | +71.4% |
| Q2 2023 | $894 | +20.8% | 271,627 | +154.0% | 0.01% | -36.4% |
| Q4 2022 | $740 | -100.0% | 106,923 | -56.0% | 0.01% | -45.0% |
| Q3 2022 | $1,539,000 | +115.2% | 243,095 | +40.7% | 0.02% | +122.2% |
| Q2 2022 | $715,000 | +114.1% | 172,759 | +150.7% | 0.01% | +125.0% |
| Q1 2022 | $334,000 | -78.7% | 68,909 | -16.1% | 0.00% | -81.0% |
| Q3 2021 | $1,570,000 | +259.3% | 82,133 | +913.7% | 0.02% | +133.3% |
| Q3 2020 | $437,000 | -68.3% | 8,102 | -64.1% | 0.01% | -75.0% |
| Q2 2020 | $1,379,000 | +241.3% | 22,585 | +413.3% | 0.04% | +157.1% |
| Q3 2019 | $404,000 | -13.9% | 4,400 | +19.4% | 0.01% | -26.3% |
| Q2 2019 | $469,000 | – | 3,686 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,964,000 | $59,215,000 | 1.36% |
| Birchview Capital, LP | 75,500 | $2,276,000 | 1.35% |
| Camber Capital Management LP | 1,000,000 | $30,150,000 | 1.04% |
| Sessa Capital IM, L.P. | 875,000 | $26,381,000 | 1.02% |
| Bain Capital Life Sciences Investors, LLC | 538,179 | $16,226,000 | 0.92% |
| Tarsadia Capital, LLC | 100,000 | $3,015,000 | 0.81% |
| Bullseye Asset Management LLC | 67,872 | $2,046,000 | 0.76% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,304,246 | $39,323,000 | 0.58% |
| MANGROVE PARTNERS IM, LLC | 175,178 | $5,282,000 | 0.53% |
| Parametrica Management Ltd | 37,712 | $1,080,000 | 0.52% |